Jump to Main Content
Triticum aestivum Sprouts Extract Inhibits Azoymethane (AOM)/Dextran Sodium Sulfate (DSS)-Induced Colon Carcinogenesis in Mice
- Ki, Hyeon-Hui, Lee, Ji-Hyun, Lee, Hoon-Yeon, Lee, Young-Mi, Kim, Dae-Ki
- Nutrition and cancer 2018 v.70 no.6 pp. 928-937
- Triticum aestivum, animal models, azoxymethane, beta catenin, carcinogenesis, cell cycle, colon, colorectal neoplasms, cyclins, dietary supplements, ethanol, genes, immunohistochemistry, inducible nitric oxide synthase, inflammation, interleukin-6, mice, oral administration, prostaglandin synthase, risk factors, sodium sulfate, staining, tissues, transcription factor NF-kappa B, tumor necrosis factor-alpha
- Chronic intestinal inflammation is critical risk factor of colorectal cancer. Triticum aestivum sprouts have been reported to provide a number of health benefits and used as a dietary supplement. In this study, the authors investigated the regulatory effects of T. aestivum sprouts ethanol extract (TAEE) on experimental colorectal carcinogenesis in an azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced mouse model. Oral administration of TAEE significantly attenuated crypt destruction and tumor formation in AOM/DSS-treated mice. Levels of inflammatory mediators involved in colorectal carcinogenesis, that is, tumor necrosis factor-α, interkeukin (IL)-1β, IL-6, cyclooxygenase-2, and inducible nitric oxide synthase, were lower in the colons of 200 mg/kg TAEE-treated mice than in AOM/DSS controls (p < 0.05). Immunohistochemical staining showed that levels of nuclear factor-kappa B p65 and β-catenin were attenuated by TAEE in the colon tissues of AOM/DSS-treated mice. Furthermore, levels of β-catenin-related genes (cyclin D1 and c-Myc), which are known to contribute to cell cycle regulation, were decreased in the colon tissues of TAEE-treated mice versus AOM/DSS controls (p < 0.01). These results showed TAEE inhibited colon inflammation and neoplasm formation caused by AOM/DSS treatment, suggesting that TAEE could be useful for the prevention and treatment of colitis-associated colon cancer.